Gramercy Surgery Center Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Gramercy Surgery Center's estimated annual revenue is currently $24.8M per year.(i)
  • Gramercy Surgery Center's estimated revenue per employee is $270,000

Employee Data

  • Gramercy Surgery Center has 92 Employees.(i)
  • Gramercy Surgery Center grew their employee count by 11% last year.

Gramercy Surgery Center's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Site DirectorReveal Email/Phone
3
Director Information TechnologyReveal Email/Phone
4
Director OperationsReveal Email/Phone
5
Director Information TechnologyReveal Email/Phone
6
Marketing ManagerReveal Email/Phone
7
Nursing ManagerReveal Email/Phone
8
Nursing ManagerReveal Email/Phone
9
Business Office ManagerReveal Email/Phone
10
Materials ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.5M30-6%N/AN/A
#2
$15.3M6315%N/AN/A
#3
$27.3M1017%N/AN/A
#4
$115.1M34116%N/AN/A
#5
$9.3M430%N/AN/A
#6
$56.7M19111%N/AN/A
#7
$65M2190%N/AN/A
#8
$57.9M1959%N/AN/A
#9
$8.6M40-11%N/AN/A
#10
$10.4M489%N/AN/A
Add Company

What Is Gramercy Surgery Center?

Gramercy Surgery Center (GSC) is a fully licensed multi-specialty Ambulatory Surgery Center (ASC) under the New York State Department of Health Article 28 regulations that provides surgeons with a friendly, high-quality, and professional setting to treat patients requiring ambulatory surgery procedures. We are a safer and more cost-efficient alternative for surgeons and their patients interested in outpatient procedures in New York City. Our commitment to quality has been recognized by Newsweek, which has ranked our facilities the #1 and #2 surgery center in NY.

keywords:N/A

N/A

Total Funding

92

Number of Employees

$24.8M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.3M923%N/A
#2
$13.3M92-8%$177.2M
#3
$12.9M92-11%$560M
#4
$13.3M92-4%N/A
#5
$23.1M928%N/A